Grand Challenge: Investigating the Oxidant Hypothesis in the Realm of Systems Physiology and Disease Pathogenesis by Cardounel, Arturo J.
www.frontiersin.org  May 2010  | Volume 1  |  Article 4  |  1
OPINION ARTICLE
published: 05 May 2010
doi: 10.3389/fphys.2010.00004
Grand challenge: investigating the oxidant hypothesis in the 
realm of systems physiology and disease pathogenesis
Arturo J. Cardounel*
Department of Physiology and Functional Genomics, University of Florida College of Medicine, Gainesville, FL, USA
*Correspondence: cardounel.1@uﬂ  .edu
Despite signiﬁ   cant advancement in our 
understanding of the role of oxidative 
stress in disease pathogenesis, the major-
ity of clinical trials examining antioxidant 
therapy and redox modifying interventions 
have failed to establish clinical beneﬁ  t. The 
lack of clinical efﬁ   cacy in human trials 
despite a wealth of literature demonstrat-
ing a clear pathogenic role of free radicals in 
disease states ranging from cardiovascular 
disease to cancer belies the need for research 
efforts into the role of oxidants in physi-
ology. With the advent of new free radical 
detection techniques, advances in molecu-
lar biology and the development of in vivo 
free radical imaging modalities, the ﬁ  eld is 
uniquely positioned to begin to unravel the 
molecular mechanisms of free radical injury 
and redox signaling within the realm sys-
tems physiology and disease pathogenesis. 
In this regard, the challenges we face lie in 
our ability to reconcile past discovery and 
current knowledge with future efforts to 
examine whether the oxidative modiﬁ  ca-
tion hypothesis is relevant to human dis-
ease. The challenges begin with identifying 
viable therapeutic targets and approaches 
to restore redox balance and ameliorate free 
radical injury and the physiological distur-
bances resulting from oxidative stress.
As a result of a large body of epidemio-
logical data showing a protective role for 
dietary antioxidants, numerous clinical 
trials have been initiated to examine the 
beneﬁ  t of supplementation with dietary 
antioxidants primarily focusing on vita-
min E, vitamin C, or ß-carotene (Jha 
et al., 1995). Unfortunately, in the major-
ity of studies, antioxidants are looked on 
as a class of compounds sharing certain 
common properties that are functionally 
considered interchangeable. There may be 
some justiﬁ  cation for such classiﬁ  cation 
when dealing with simple in-vitro redox 
systems, however, there are striking dif-
ferences with regards to there chemical 
properties. For example, ß-carotene is an 
excellent scavenger of singlet oxygen but 
much less effective at terminating free radi-
cal chain reactions; the reverse is true of 
vitamin E (Packer et al., 1981). In the con-
text of a complex biological system, such 
aggregate classiﬁ  cation becomes hard to 
defend. For example, vitamin C is water-
soluble, readily absorbed, and transported 
in the aqueous phase of the plasma; vitamin 
E is lipophilic, poorly absorbed in the GI 
tract, and transported with plasma proteins 
(Padayatty et al., 2004; Rigotti, 2007). The 
pharmacodynamics of the various antioxi-
dants also differ greatly, and until we know 
where and how these agents function, we 
have no way to predict which antioxidant, 
at what dosage and administered by what 
route, will be most effective. An analysis 
of the hypothesis and the trial literature, 
points out major misconceptions about the 
hypothesis and unjustiﬁ  ed outcome expec-
tations of antioxidant trials. In response, 
future efforts in the ﬁ  eld of oxidant physi-
ology should include: (1) identiﬁ  cation 
of novel and selective biochemical and 
biological markers of oxidative stress; (2) 
informed antioxidant selection based on 
comprehensive pharmacokinetic proﬁ  les 
and identiﬁ  cation of physiological targets 
of action; and (3) establishment of selec-
tion criteria for patient recruitment.
Through their effects on proteins, DNA 
and membranes, oxidizing and reducing 
agents play a critical role in regulating a 
myriad of cellular functions. Our goal is to 
publish research related to furthering the 
understanding of the integrative mecha-
nisms of redox signaling in the control 
of complex physiological function. This 
aspect is critical to our ability to understand, 
manage and treat diseases associated with 
oxidant stress and impaired antioxidant 
defenses. Because of the integrative nature 
of the specialty section, the scope of arti-
cles that will be considered is broad, and 
includes work elucidating genetic, biophysi-
cal, genomic, proteomic, cellular, molecular, 
biochemical, physiological and pharmaco-
logical aspects of oxidants and redox active 
molecules, as well as the pathological events 
associated with oxidants stress. Free radical 
imaging studies and clinical studies targeted 
to mechanistic aspects of oxidative stress are 
also welcome.
In conclusion, new technologies and 
animal models of disease will continue by 
ingenious innovations to make inroads 
in our understanding of the role oxidants 
play in physiology and medicine. The use 
of novel molecular, genetic and imaging 
approaches will undoubtedly provide fun-
damental advances in the realm of oxidant 
physiology. This is the good news! The 
bad news is that we need to wait to ﬁ  nd 
out how.
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